R. Rappuoli, C. W. Mandl, S. Black, D. Gregorio, and E. , Vaccines for the twenty-first century society, Nat Rev Immunol, vol.11, issue.12, p.22051890, 2011.

S. A. Plotkin, Correlates of protection induced by vaccination, Clin Vaccine Immunol, vol.17, issue.7, p.2897268, 2010.

D. R. Burton and L. Hangartner, Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design, Annu Rev Immunol, vol.34, p.6034635, 2016.

P. S. Lee and I. A. Wilson, Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies, Curr Top Microbiol Immunol, vol.386, p.4358778, 2015.

M. S. Gilman, C. A. Castellanos, M. Chen, J. O. Ngwuta, E. Goodwin et al., Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors, Sci Immunol, vol.1, issue.6, p.5244814, 2016.

J. S. Mclellan, Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein, Curr Opin Virol, vol.11, p.4456247, 2015.

G. Barba-spaeth, W. Dejnirattisai, A. Rouvinski, M. C. Vaney, I. Medits et al., Structural basis of potent Zika-dengue virus antibody cross-neutralization, Nature, vol.536, issue.7614, pp.48-53, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01408100

D. F. Robbiani, L. Bozzacco, J. R. Keeffe, R. Khouri, P. C. Olsen et al., Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico, Cell, vol.169, issue.4, p.5492969, 2017.

M. Xu, R. Zuest, S. Velumani, F. Tukijan, Y. X. Toh et al., A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus, NPJ Vaccines, vol.2, p.5627287, 2017.

Z. A. Bornholdt, H. L. Turner, C. D. Murin, W. Li, D. Sok et al., Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak, Science, vol.351, issue.6277, p.4900763, 2016.

S. Chandramouli, E. Malito, T. Nguyen, K. Luisi, D. Donnarumma et al., Structural basis for potent antibody-mediated neutralization of human cytomegalovirus, Sci Immunol, vol.2, issue.12, p.28783665, 2017.

K. M. Hastie, M. A. Zandonatti, L. M. Kleinfelter, M. L. Heinrich, M. M. Rowland et al., Structural basis for antibody-mediated neutralization of Lassa virus, Science, vol.356, issue.6341, p.6007842, 2017.

S. C. Harrison, Viral membrane fusion, Virology, p.4424100, 2015.

D. Corti, J. Voss, S. J. Gamblin, G. Codoni, A. Macagno et al., A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins, Science, vol.333, issue.6044, p.21798894, 2011.

J. S. Mclellan, M. Chen, S. Leung, K. W. Graepel, X. Du et al., Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody, Science, vol.340, issue.6136, p.4459498, 2013.

D. R. Burton, Antibodies, viruses and vaccines, Nat Rev Immunol, vol.2, issue.9, pp.706-719, 2002.

D. R. Burton, What Are the Most Powerful Immunogen Design Vaccine Strategies? Reverse Vaccinology 2.0 Shows Great Promise, Cold Spring Harb Perspect Biol, vol.9, issue.11, p.5540812, 2017.

R. Rappuoli, M. J. Bottomley, D. 'oro, U. Finco, O. et al., Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design, J Exp Med, vol.213, issue.4, p.4821650, 2016.

J. S. Mclellan, M. Chen, M. G. Joyce, M. Sastry, G. B. Stewart-jones et al., Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus, Science, vol.342, issue.6158, p.4461862, 2013.

A. Impagliazzo, F. Milder, H. Kuipers, M. V. Wagner, X. Zhu et al., A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen, Science, vol.349, issue.6254, p.26303961, 2015.

H. M. Yassine, J. C. Boyington, P. M. Mctamney, C. J. Wei, M. Kanekiyo et al., Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection, Nat Med, vol.21, issue.9, p.26301691, 2015.

B. E. Correia, J. T. Bates, R. J. Loomis, G. Baneyx, C. Carrico et al., Proof of principle for epitopefocused vaccine design, Nature, vol.507, issue.7491, p.4260937, 2014.

B. B. Finlay and G. Mcfadden, Anti-immunology: evasion of the host immune system by bacterial and viral pathogens, Cell, vol.124, issue.4, p.16497587, 2006.

S. F. Andrews, Y. Huang, K. Kaur, L. I. Popova, I. Y. Ho et al., Immune history profoundly affects broadly protective B cell responses to influenza, Sci Transl Med, vol.7, issue.316, p.4770855, 2015.

D. Angeletti, J. S. Gibbs, M. Angel, I. Kosik, H. D. Hickman et al., Defining B cell immunodominance to viruses, Nat Immunol, vol.18, issue.4, p.28192417, 2017.

P. Central and P. , , p.5360521

V. I. Zarnitsyna, A. H. Ellebedy, C. Davis, J. Jacob, R. Ahmed et al., Masking of antigenic epitopes by antibodies shapes the humoral immune response to influenza, Philos Trans R Soc Lond B Biol Sci, vol.370, p.4528424, 1676.

V. I. Zarnitsyna, J. Lavine, A. Ellebedy, R. Ahmed, and R. Antia, Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to Influenza, PLoS Pathog, vol.12, issue.6, p.4918916, 2016.

G. D. Victora and M. C. Nussenzweig, Germinal centers, Annu Rev Immunol, vol.30, p.22224772, 2012.

B. Briney, D. Sok, J. G. Jardine, D. W. Kulp, P. Skog et al., Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies, Cell, vol.166, issue.6, p.5018249, 2016.

J. G. Jardine, T. Ota, D. Sok, M. Pauthner, D. W. Kulp et al., HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen, Science, vol.349, issue.6244, p.4669217, 2015.

M. Silva, T. H. Nguyen, P. Philbrook, M. Chu, O. Sears et al., Targeted Elimination of Immunodominant B Cells Drives the Germinal Center Reaction toward Subdominant Epitopes, Cell Rep, vol.21, issue.13, p.5771444, 2017.

J. C. Boyington, M. G. Joyce, M. Sastry, G. B. Stewart-jones, M. Chen et al., Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus, PLoS ONE, vol.11, issue.7, p.4963090, 2016.

G. A. Kirchenbaum, D. M. Carter, and T. M. Ross, Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies, J Virol, vol.90, issue.2, p.4702689, 2016.

K. Van-reeth, J. Gracia, I. Trus, L. Sys, G. Claes et al., Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection. NPJ Vaccines, vol.2, p.5604745, 2017.

C. J. Wei, J. C. Boyington, P. M. Mctamney, W. P. Kong, M. B. Pearce et al., Induction of broadly neutralizing H1N1 influenza antibodies by vaccination, Science, vol.329, issue.5995, p.20647428, 2010.

P. L. Herve, C. Deloizy, D. Descamps, M. A. Rameix-welti, J. Fix et al., RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine, Nanomedicine, vol.13, issue.2, p.27553073, 2017.

X. Roux, C. Dubuquoy, G. Durand, T. L. Tran-tolla, N. Castagne et al., Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus, PLoS ONE, vol.3, issue.3, p.2262139, 2008.

R. G. Tawar, S. Duquerroy, C. Vonrhein, P. F. Varela, L. Damier-piolle et al., Crystal structure of a nucleocapsid-like nucleoprotein-RNA complex of respiratory syncytial virus, Science, vol.326, issue.5957, pp.1279-83, 2009.
URL : https://hal.archives-ouvertes.fr/pasteur-00457523

B. E. Correia, Y. E. Ban, D. J. Friend, K. Ellingson, H. Xu et al., Computational protein design using flexible backbone remodeling and resurfacing: case studies in structure-based antigen design, J Mol Biol, vol.405, issue.1, p.20969873, 2011.

B. Kuhlman and D. Baker, Native protein sequences are close to optimal for their structures, Proc Natl Acad Sci, vol.97, issue.19, p.27033, 2000.

H. Wu, D. S. Pfarr, S. Johnson, Y. A. Brewah, R. M. Woods et al., Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract, J Mol Biol, vol.368, issue.3, p.17362988, 2007.

M. G. Joyce, B. Zhang, L. Ou, M. Chen, G. Y. Chuang et al., Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV, Nat Struct Mol Biol, vol.23, issue.9, p.5016229, 2016.

J. S. Mclellan, B. E. Correia, M. Chen, Y. Yang, B. S. Graham et al., Design and characterization of epitope-scaffold immunogens that present the motavizumab epitope from respiratory syncytial virus, J Mol Biol, vol.409, issue.5, p.3107930, 2011.

J. S. Mclellan, M. Chen, A. Kim, Y. Yang, B. S. Graham et al., Structural basis of respiratory syncytial virus neutralization by motavizumab, Nat Struct Mol Biol, vol.17, issue.2, p.3050594, 2010.

J. L. Xu and M. M. Davis, Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities, Immunity, vol.13, issue.1, p.10933393, 2000.

J. F. Scheid, H. Mouquet, B. Ueberheide, R. Diskin, F. Klein et al., Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding, Science, vol.333, issue.6049, p.3351836, 2011.

E. Goodwin, M. Gilman, D. Wrapp, M. Chen, J. O. Ngwuta et al., Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation, Immunity, vol.48, issue.2, p.6005179, 2018.

S. Friedensohn, T. A. Khan, and S. T. Reddy, Advanced Methodologies in High-Throughput Sequencing of Immune Repertoires, Trends Biotechnol, vol.35, issue.3, p.28341036, 2017.

N. L. Kallewaard, D. Corti, P. J. Collins, U. Neu, J. M. Mcauliffe et al., Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes, Cell, vol.166, issue.3, p.4967455, 2016.

F. Sesterhenn, J. Bonet, and B. E. Correia, Structure-based immunogen design-leading the way to the new age of precision vaccines, Curr Opin Struct Biol, vol.51, p.29980105, 2018.

G. Ofek, F. J. Guenaga, W. R. Schief, J. Skinner, D. Baker et al., Elicitation of structure-specific antibodies by epitope scaffolds, Proc Natl Acad Sci, vol.107, issue.42, p.2964213, 2010.

N. Jaberolansar, K. J. Chappell, D. Watterson, I. M. Bermingham, I. Toth et al., Induction of high titred, non-neutralising antibodies by self-adjuvanting peptide epitopes derived from the respiratory syncytial virus fusion protein, Sci Rep, vol.7, issue.1, p.5593926, 2017.

R. K. Abbott, J. H. Lee, S. Menis, P. Skog, M. Rossi et al., Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens, Immunity, vol.48, issue.1, p.5773359, 2018.

B. E. Correia, Y. E. Ban, M. A. Holmes, H. Xu, K. Ellingson et al., Computational design of epitopescaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope. Structure, vol.18, p.20826338, 2010.

G. D. Victora and P. C. Wilson, Germinal Center Selection and the Antibody Response to Influenza, Cell, vol.163, issue.3, pp.545-553, 2015.

P. Tsui, M. A. Tornetta, R. S. Ames, B. C. Bankosky, S. Griego et al., Isolation of a neutralizing human RSV antibody from a dominant, non-neutralizing immune repertoire by epitope-blocked panning, Journal of Immunology, vol.157, issue.2, 1996.

I. Widjaja, O. Wicht, W. Luytjes, K. Leenhouts, P. Rottier et al., Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV, J Virol, vol.90, issue.13, p.4907225, 2016.

S. F. Andrews, K. Kaur, N. T. Pauli, M. Huang, Y. Huang et al., High preexisting serological antibody levels correlate with diversification of the influenza vaccine response, J Virol, vol.89, issue.6, p.4337521, 2015.

K. Xu, P. Acharya, R. Kong, C. Cheng, G. Y. Chuang et al., Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1, Nat Med, vol.24, issue.6, p.29867235, 2018.

Y. Li, J. L. Myers, D. L. Bostick, C. B. Sullivan, J. Madara et al., Immune history shapes specificity of pandemic H1N1 influenza antibody responses, J Exp Med, vol.210, issue.8, p.3727314, 2013.

D. C. Ekiert, R. H. Friesen, G. Bhabha, T. Kwaks, M. Jongeneelen et al., A highly conserved neutralizing epitope on group 2 influenza A viruses, Science, vol.333, issue.6044, p.3210727, 2011.

D. D. Raymond, G. Bajic, J. Ferdman, P. Suphaphiphat, E. C. Settembre et al., Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody, Proc Natl Acad Sci U S A, vol.115, issue.1, p.5776812, 2018.

W. Dejnirattisai, P. Supasa, W. Wongwiwat, A. Rouvinski, G. Barba-spaeth et al., Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus, Nat Immunol, vol.17, issue.9, p.4994874, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-02003950

L. C. Katzelnick, L. Gresh, M. E. Halloran, J. C. Mercado, G. Kuan et al., Antibody-dependent enhancement of severe dengue disease in humans, Science, vol.358, issue.6365, p.5858873, 2017.

J. Bonet, S. Wehrle, K. Schriever, C. Yang, A. Billet et al., Rosetta FunFolDes-A general framework for the computational design of functional proteins, PLoS Comput Biol, vol.14, issue.11, p.6277116, 2018.

F. Sievers, A. Wilm, D. Dineen, T. J. Gibson, K. Karplus et al., Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega, Mol Syst Biol, vol.7, p.3261699, 2011.

N. Castagne, A. Barbier, J. Bernard, H. Rezaei, J. C. Huet et al., Biochemical characterization of the respiratory syncytial virus P-P and P-N protein complexes and localization of the P protein oligomerization domain, J Gen Virol, vol.85, p.15166449, 2004.

A. Rohou and N. Grigorieff, CTFFIND4: Fast and accurate defocus estimation from electron micrographs, J Struct Biol, vol.192, issue.2, p.26278980, 2015.

J. M. De-la-rosa-trevin, A. Quintana, D. Cano, L. Zaldivar, A. Foche et al., Scipion: A software framework toward integration, reproducibility and validation in 3D electron microscopy, J Struct Biol, vol.195, issue.1, p.27108186, 2016.

S. H. Scheres, RELION: implementation of a Bayesian approach to cryo-EM structure determination, J Struct Biol, vol.180, issue.3, p.3690530, 2012.

D. W. Kulp, J. M. Steichen, M. Pauthner, X. Hu, T. Schiffner et al., Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding, Nat Commun, vol.8, issue.1, p.5698488, 2017.

T. A. Khan, S. Friedensohn, A. R. Gorter-de-vries, J. Straszewski, H. J. Ruscheweyh et al., Accurate and predictive antibody repertoire profiling by molecular amplification fingerprinting, Sci Adv, vol.2, issue.3, p.4795664, 2016.

S. Friedensohn, J. M. Lindner, V. Cornacchione, M. Iazeolla, E. Miho et al., Synthetic Standards Combined With Error and Bias Correction Improve the Accuracy and Quantitative Resolution of Antibody Repertoire Sequencing in Human Naive and, Memory B Cells. Front Immunol, vol.9, p.6019461, 2018.

Z. Gu, L. Gu, R. Eils, M. Schlesner, and B. Brors, circlize Implements and enhances circular visualization in R, Bioinformatics, vol.30, p.24930139, 2014.

J. Ou, S. A. Wolfe, M. H. Brodsky, and L. J. Zhu, motifStack for the analysis of transcription factor binding site evolution, Nat Methods, vol.15, issue.1, p.29298290, 2018.

M. A. Rameix-welti, L. Goffic, R. Herve, P. L. Sourimant, J. Remot et al., Visualizing the replication of respiratory syncytial virus in cells and in living mice, Nat Commun, vol.5, p.5104, 2014.